ABOUT US
Board of directorsWyle Solomon
Hans T. Schambye
Torsten Goesch
Management
Scientific advisors
Investors
Wyle Solomon , MSc, MBA
Chairman
Wyle Solomon joined the Forward Pharma A/S Board of Directors in 2008 and has served as Chairman since 2010. He possesses over 20 years experience in the development and regulation of pharmaceuticals as well as in business and corporate development.
Wyle is a Venture Partner at Nordic Biotech Advisors where he serves on the board and as executive management of portfolio companies. He previously held the positions of: Vice President, Drug Development and Regulatory Affairs at Nordic Biotech; Director, Commercial and Business Development at Mylan; Head of regulatory affairs and pharmaceutical development at Achillion Pharmaceuticals; and positions of increasing responsibility at Bristol-Myers Squibb as a scientist in oncology drug discovery and in regulatory affairs.
Wyle holds an MSc from Temple University School of Pharmacy in Pennsylvania and an MBA from McGill University School of Management in Montréal.
Hans T. Schambye, MD, PhD
Board member
Hans Schambye is an independent biotech consultant and board member. Read more.
Torsten Goesch, MD, PhD, MBA
Board member
Dr. Torsten Goesch is a director of Rosetta Capital, formerly BioScience Managers Limited (BML) Read more.
